Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets

Area of Science:

• Cardiovascular Biology
• Endothelial Function
• Molecular Medicine

Background:

• Nitric oxide (NO) produced by endothelial cells is crucial for cardiovascular homeostasis.
• Diminished NO bioavailability and endothelial dysfunction are hallmarks of cardiovascular disease.
• Endothelial nitric oxide synthase (eNOS) synthesizes NO using L-arginine (L-Arg) and tetrahydrobiopterin (BH4).

Discussion:

• Cardiovascular risk factors induce oxidative stress, impairing eNOS activity and causing eNOS uncoupling.
• Uncoupled eNOS generates superoxide anions, exacerbating oxidative stress and endothelial dysfunction.
• Key mechanisms of eNOS uncoupling include BH4 depletion, L-Arg deficiency, ADMA accumulation, and S-glutathionylation.

Key Insights:

• eNOS uncoupling is a central mechanism in the pathogenesis of vascular diseases.
• Oxidative stress significantly impacts eNOS function and NO bioavailability.
• Understanding eNOS uncoupling mechanisms is vital for cardiovascular disease research.

Outlook:

• Therapeutic strategies targeting eNOS uncoupling are under investigation.
• Improving BH4 availability may restore eNOS function.
• Restoring the L-Arg/ADMA ratio and modulating eNOS S-glutathionylation are potential therapeutic avenues.